NK Cell Engagers: A Deep Dive in Targets for Cancer IO

When:  Jan 11, 2023 from 10:00 to 12:00 (CT)
This webinar, the ninth and final session of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind natural killer cell engagers. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target audience of this series.

Moderators:
  • Adelheid Cerwenka, PhD – Heidelberg University
  • Lewis L. Lanier, PhD – University of California, San Francisco
Faculty:
  • TBD

Learn more about the 2022 Targets for Cancer IO: A Deep Dive Series here!

Targets for Cancer IO: A Deep Dive Series is supported, in part, by educational grants from Genmab, US, Inc. and Merck & Co., Inc. (as of 6/6/2022).

#TargetsforCancerImmunotherapyADeepDiveSeminarSeries #NoCEOffered #Industry #Researcher #2022